Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus
Chalouni M, Van Santen D, Berenguer J, Jarrin I, Miro J, Klein M, Young J, Torgersen J, Rentsch C, Gill M, Epstein R, Linas B, Zangerle R, Surial B, Rauch A, Touloumi G, Papadopoulos A, Wittkop L, Van Der Valk M, Boyd A, Monforte A, Puoti M, Logan R, Rein S, Hernán M, Lodi S. Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus. AIDS 2025, 39: 1074-1079. PMID: 39970192, PMCID: PMC12122233, DOI: 10.1097/qad.0000000000004161.Peer-Reviewed Original ResearchRisk of liver-related eventsDirect-acting antivirals initiationHIV-HCV co-infectionLiver-related eventsDirect-acting antiviralsHIV virologic suppressionAntiretroviral treatmentVirologic suppressionHIV-HCVCo-InfectionHistory of injection drug useInjection drug useHepatitis C virusAntiviral initiationSuppress HIVDAA initiationHCV transmissionC virusEarly initiationCure HCVDelayed initiationHIVRisk differenceClinical practiceDrug use
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply